Qualigen in-licenses novel cancer drug from University of Louisville (UofL)

CARLSBAD, Calif., July 12, 2018 /PRNewswire/ -- Qualigen, Inc., and the University of Louisville (UofL) today announced that Qualigen has licensed certain UofL patents, intellectual property and other assets associated with......
. .
Veröffentlicht von: Finanzen.at - Nachrichten Ticker - 7 days ago

Share |